Publications
- Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer? +12005 | Faculty of Medicine in Hradec Králové
- Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?2005 | Publication without faculty affiliation
- Radiační onkologie2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine, Faculty of Medicine in Pilsen
- Controversies of radiotherapy in human epidermal growth factor receptor (HER)-2 positive breast cancer patients2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Preoperative CT for postoperative radiotherapy planning in breast cancer2021 | First Faculty of Medicine, Third Faculty of Medicine
- Deep-inspiration breath hold radiotherapy in patients with left-sided breast cancer after partial mastectomy2021 | First Faculty of Medicine, Third Faculty of Medicine
- Monitoring of patients with prostate cancer after external radiotherapy2021 | First Faculty of Medicine
- Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer2020 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Third Faculty of Medicine
- Giant locally advanced and metastatic squamous cell skin carcinoma of head and neck region: case report2020 | First Faculty of Medicine, Third Faculty of Medicine
- Long-Term Clinical Results of IGRT in Prostate Cancer Treatment2020 | First Faculty of Medicine, Third Faculty of Medicine
Loading network view...